Literature DB >> 22578956

Mutational analysis of the NPHS2 gene in Czech patients with idiopathic nephrotic syndrome.

J Reiterová1, H Safránková, L Obeidová, J Stěkrová, D Maixnerová, M Merta, V Tesař.   

Abstract

Focal segmental glomerulosclerosis and minimal change disease represent frequent histological patterns of renal injury in patients with nephrotic syndrome. Few cases carrying NPHS2 gene variants have been described to date. Mutational analysis of the NPHS2 gene was performed in 50 Czech adult patients with histologically proved FSGS/MCD. The common p.P20L and p.R229Q polymorphisms of the NPHS2 gene were tested in 169 patients with IgA nephropathy and in 300 individuals of the control group. No mutation in the NPHS2 gene in patients with adult onset was identified. One homozygous mutation p.V290M in a patient with onset in early childhood was found. One new heterozygous variant in the non-conservative area of the NPHS2 gene, p.G97S, was identified in a patient with childhood-onset FSGS. In one adult patient, there were two polymorphisms, p.P20L and p.R229Q, in trans-heterozygous state, which could contribute to steroid-resistant nephrotic syndrome. The most common polymorphism p.R229Q was identified in 12 % of FSGS/ MCD patients, in 11.8 % of IGAN patients and in 10% of controls. The heterozygosity of p.R229Q polymorphism was similar in the IGAN group, with non-significantly higher prevalence in IGAN patients with progressive form of the disease (15.9 % versus 9.4 %). The prevalence of p.P20L polymorphism was not significantly different among the groups (6 % in FSGS patients, 1.8 % in IGAN patients, 1 % in the control group). To conclude, NPHS2 mutations are rare in patients with adult onset of FSGS/MCD. The R229Q polymorphism is frequent in the Czech population and probably could have some influence on IGAN.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22578956

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  7 in total

1.  NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosis.

Authors:  Andrea Kerti; Rózsa Csohány; László Wagner; Eszter Jávorszky; Erika Maka; Kálmán Tory
Journal:  Pediatr Nephrol       Date:  2013-06-26       Impact factor: 3.714

2.  The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis.

Authors:  Lu Lu; Heng Wan; Yi Yin; Wen-Jun Feng; Ming Wang; Yu-Cong Zou; Bo Huang; Dong-Tao Wang; Yin Shi; Yan Zhao; Lian-Bo Wei
Journal:  Int Urol Nephrol       Date:  2014-04-09       Impact factor: 2.370

3.  Prevalence of NPHS2 gene R229Q polymorphism in Bangladeshi children with nephrotic syndrome.

Authors:  Sharmin Sultana Jyoti; Farhana Islam; Ishrat Islam Shrabonee; Taposhi Nahid Sultana; Nusrat Islam Chaity; Noor Ahmed Nahid; Md Reazul Islam; Md Saiful Islam; Mohd Nazmul Hasan Apu
Journal:  Heliyon       Date:  2020-10-20

4.  NPHS2 p.V290M mutation in late-onset steroid-resistant nephrotic syndrome.

Authors:  Andrea Kerti; Rózsa Csohány; Attila Szabó; Ottó Arkossy; Péter Sallay; Vincent Moriniére; Virginia Vega-Warner; Gábor Nyírő; Orsolya Lakatos; Tamás Szabó; Beata S Lipska; Franz Schaefer; Corinne Antignac; George Reusz; Tivadar Tulassay; Kálmán Tory
Journal:  Pediatr Nephrol       Date:  2012-12-14       Impact factor: 3.714

5.  R229Q Polymorphism of NPHS2 Gene in Group of Iraqi Children with Steroid-Resistant Nephrotic Syndrome.

Authors:  Shatha Hussain Ali; Rasha Kasim Mohammed; Hussein Ali Saheb; Ban A Abdulmajeed
Journal:  Int J Nephrol       Date:  2017-04-26

6.  Association Between NPHS2 p.R229Q and Focal Segmental Glomerular Sclerosis/Steroid-Resistant Nephrotic Syndrome.

Authors:  Qiongxiu Zhou; Qinjie Weng; Xiaoyan Zhang; Yunzi Liu; Jun Tong; Xu Hao; Hao Shi; Pingyan Shen; Hong Ren; Jingyuan Xie; Nan Chen
Journal:  Front Med (Lausanne)       Date:  2022-07-22

7.  Analysis of NPHS2 Gene Mutations in Egyptian Children with Nephrotic Syndrome.

Authors:  Moushira Zaki; Shreen El-Shaer; Sahar Rady; Manal Abd El-Salam; Ragaa Abd-El-Salam; Ibrahim Abdelfattah Alkashlan; Mohamed Saber; Sanaa Mohamed; Mohamed Hassaan; Eman Rabie; Khalda Amr
Journal:  Open Access Maced J Med Sci       Date:  2019-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.